1-832-868-1888

order@swbio.com

Home > products > CD137 Antibody

CD137 Antibody

Catalog Number:

48126
other_names: 4 1BB antibody
4 1BB ligand receptor antibody
4-1BB ligand receptor antibody
4-1BB Ligand Receptor T Cell antibody
4-1BB, mouse, homolog of antibody
Antigen 4-1BB Homolog antibody
CD 137 antibody
CD137 antibody
CD137 antigen antibody
CDw137 antibody
HLDA VI antibody
Homolog of mouse 4 1BB antibody
ILA antibody
induced by lymphocyte activation (ILA) antibody
Induced by lymphocyte activation antibody
Interleukin activated receptor homolog of mouse Ly63 antibody
Ly63, mouse, homolog of antibody
MGC2172 antibody
OTTHUMP00000044294 antibody
Receptor protein 4 1BB antibody
T cell antigen 4 1BB homolog antibody
T cell antigen ILA antibody
T-cell antigen 4-1BB homolog antibody
T-cell antigen ILA antibody
TNF receptor superfamily member 9 antibody
TNFRSF9 antibody
TNR9_HUMAN antibody
Tumor necrosis factor receptor superfamily member 9 antibody

Amount:

100μg
calculated_mw: 35 kDa
host_species: Mouse

Price:

$529

Swiss-Prot No:

Swiss-Prot#:Q07011

Form of Antibody:

1*TBS (pH7.4), 0.5%BSA, 50%Glycerol. Preservative: 0.05% Sodium Azide.

Storage/Stability:

Immunogen:

Recombinant protein

Purification:

ProA affinity purified

Specificity/Sensitivity:

Applications:

WB, IHC, ICC, FC

Background:

CD137, also designated ILA and 4-1BB in mouse, belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. CD137 is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages, and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. Crosslinking of the CD137 ligand induces apoptosis in resting lymphocytes. In contrast, CD137 regulates peripheral monocyte survival by inducing a cytokine release profile, and is mediated by M-CSF and to a lesser extent by granulocyte-macrophage colony-stimulating factor and IL-3. Soluble forms of CD137 are found in sera from patients with rheumatoid arthritis and may provide a negative control mechanism for immune responses.

References:

appl_detail:

WB: 1:500
IHC: 1:50-1:200
ICC: 1:100-1:500

FC: 1:50-1:200

Datasheet PDF

Product Search

CONTACT US

1-832-868-1888 order@swbio.com

GET IN TOUCH

© Signalway Biotechnology All Rights Reserved.
Powered by Signalway | Sitemap